Tracy Liu - 17 Sep 2025 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Role
Director
Signature
/s/ Mark McKechnie, Attorney-in-Fact for Tracy Liu
Issuer symbol
ACMR
Transactions as of
17 Sep 2025
Net transactions value
-$480,000
Form type
4
Filing time
19 Sep 2025, 16:30:14 UTC
Previous filing
14 Aug 2025
Next filing
12 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Liu Tracy Director C/O ACM RESEARCH, INC., 42307 OSGOOD ROAD, SUITE I, FREMONT /s/ Mark McKechnie, Attorney-in-Fact for Tracy Liu 19 Sep 2025 0001721299

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACMR Class A Common Stock Options Exercise $15,000 +15,000 +14% $1.00 125,772 17 Sep 2025 Direct F1
transaction ACMR Class A Common Stock Sale $495,000 -15,000 -12% $33.00 110,772 17 Sep 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACMR Stock Option Options Exercise $0 -15,000 -20% $0.000000 60,000 17 Sep 2025 Class A Common Stock 15,000 $1.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 On September 17, 2025, the reporting person exercised a previously issued stock option to purchase 15,000 shares of Class A Common Stock of the Issuer.
F2 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025.
F3 The option is fully vested and exercisable.